To match clinical needs, the new platform integrates as-existed high-throughput gene sequencing platform and data-analysis supporting system, and builds up disease-related gene testing service lines. It implements R&D of the disease-risk detection kit with next-generation sequencing technology, particularly aims to achieve new breakthrough in the R&D of risk detection kits for congenital defects such as Down syndrome and hereditary metabolic diseases.